with the butanol extract the mean lymphocyte adherence inhibition reactivity of the 62 tests done on renal cancer patients ( 38.9 +/- 10.8 per cent ) was significantly greater than either control group ( 7.1 +/- 6.2 per cent , p less than 0.001 for benign renal disease and 5.9 +/- 2.6 per cent , p less than 0.001 for bladder tumor ) .
C0740457
renal cancer
C0022646
renal